Research field (3)：
Functional biochemistry
, Molecular biology
, Tumor biology
Research keywords (1)：
One Carbon Metabolism
Research theme for competitive and other funds (3)：
2021 - 2024 Elucidation of synergistic mechanisms in the combination of chemotherapy and PD-1/L1 inhibitors and exploration for novel therapeutic targets
2019 - 2022 Basic Research Toward Precision Medicine Using Human Lung Cancer Organoids
2016 - 2018 Role of Kras mutations in intestinal tumor progression
Papers (28)：
Hiroaki Akamatsu, Shunsuke Teraoka, Shinkichi Takamori, Satoru Miura, Hidetoshi Hayashi, Akito Hata, Yukihiro Toi, Yoshimasa Shiraishi, Nobuaki Mamesaya, Yuki Sato, et al. Nivolumab Retreatment in Non-Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L). Clinical cancer research : an official journal of the American Association for Cancer Research. 2022. OF1-OF7
